Dreher N, Dorrler AL, Kraus S, Higuchi T, et al. C-X-C Motif Chemokine Receptor 4-Targeted Radioligand Therapy in Hematological Malignancies-Myeloablative Effects, Antilymphoma Activity, and Safety Profile. Clin Nucl Med 2024;49:146-151.
PMID: 38081189